comparemela.com
Home
Live Updates
Immunic, Inc. to Participate in Investor and Scientific Conferences in February : comparemela.com
Immunic, Inc. to Participate in Investor and Scientific Conferences in February
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at...
Related Keywords
Edna Kaplan ,
Paula Schwartz ,
Jessica Breu ,
Evelyn Peelen ,
Daniel Vitt ,
Exchange Commission ,
Colitis Organization ,
Rx Communications Group ,
Prnewswire Immunic Inc ,
Nasdaq ,
Immunic Inc ,
Aegis Capital Corp ,
Annual Global Healthcare ,
Chief Executive Officer ,
European Crohn ,
Senior Manager Translational Pharmacology ,
Small Molecule ,
Ulcerative Colitis ,
Shows Potent Anti Inflammatory Activity ,
Vivo Systems ,
Virtual Poster Exhibition ,
Basic Science ,
Aegis Capital ,
Private Securities Litigation Reform Act ,
Annual Report ,
Investor Relations ,
Immunic ,
Nc ,
comparemela.com © 2020. All Rights Reserved.